Key Tip: Whether women with a history of pregnancy loss should undergo non-invasive prenatal testing (NIPT) during subsequent pregnancies to ensure fetal health is a question that requires comprehensive consideration of multiple factors.

For women who have experienced a pregnancy loss, determining whether to undergo non-invasive prenatal testing (NIPT) during subsequent pregnancies to ensure fetal health is a decision that necessitates careful evaluation of various factors.

Fetal demise refers to the cessation of fetal development during pregnancy. Women with a history of fetal demise may face increased risk of fetal chromosomal abnormalities in subsequent pregnancies. Non-invasive prenatal testing (NIPT) is a screening method that analyzes cell-free fetal DNA in maternal blood to detect chromosomal abnormalities without invasive procedures. This technique can identify common chromosomal disorders such as Down syndrome, Edwards syndrome, and Patau syndrome at an early stage. For women with previous fetal demise, NIPT provides earlier insight into fetal health status, enabling timely medical interventions.

However, NIPT has certain limitations and risks. While offering high accuracy, NIPT still carries false positive and false negative rates, meaning not all abnormalities will be detected and some results may be incorrect. NIPT cannot replace traditional prenatal screening and diagnostic methods such as amniocentesis or chorionic villus sampling. Finally, NIPT results require comprehensive evaluation with other clinical information to determine appropriate subsequent management.

Health Management Tips:

1. Consult your physician regarding the need for NIPT.

2. Undergo regular prenatal check-ups to monitor fetal development.

3. Seek immediate medical attention for further examination if any abnormalities occur.